Neoadjuvant Immune Checkpoint Blockade: A Window into Treatment Response and Pri
PharmaTalkRadio13 Jan 2023

Neoadjuvant Immune Checkpoint Blockade: A Window into Treatment Response and Pri

Neoadjuvant (pre-surgical) immune checkpoint blockade may prevent cancer relapse and progression.This treatment approach is now FDA-approved for resectable triple-negative breast cancer, and hundreds of clinical trials in other cancers are ongoing.Surgical resection specimens collected after several weeks of neoadjuvant ICB offer vast opportunities for predictive biomarker discovery and understanding ICB response/resistance. Suzanne Topalian, MD, Associate Director / Professor of Surgery, Bloomberg~Kimmel Institute for Cancer Immunotherapy / Johns Hopkins University Learn more about the IO360° Summit at www.io360summit.com

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(461)

Populært innen Vitenskap

fastlegen
tingenes-tilstand
romkapsel
sinnsyn
dekodet-2
liberal-halvtime
rss-nysgjerrige-norge
forskningno
rekommandert
fjellsportpodden
rss-paradigmepodden
rss-rekommandert
grunnstoffene
tidlose-historier
villmarksliv
nordnorsk-historie
rss-bondevennen
hva-er-greia-med
vett-og-vitenskap-med-gaute-einevoll
noen-har-snakket-sammen